This once-daily, oral medication blocks a protein in B cells called Bruton's tyrosine kinase, or BTK. For more complete information on how IMBRUVICA® works and the possible side effects, go to the How Does IMBRUVICA® Work? section.1 With IMBRUVICA®, there’s a once-daily oral ...
The most common side effects of IMBRUVICA® in adults with B-cell malignancies (CLL/SLL and WM) includelow platelet count; diarrhea; tiredness; muscle, bone, and joint pain; low white blood cell count; rash; low red blood cell count (anemia); bruising; and nausea. ...
While recent efforts have developed more selective BTK inhibitors in an effort to decrease medication side effects, these results indicate that off-target immunomodulatory effects may be an underappreciated benefit from ibrutinib treatment.Max Yano
Please see the RituxanPrescribing InformationandMedication Guideincluding Most Serious Side Effects for additional Important Side Effect Information.
For patients at increased risk of hypertensive crisis, consider the benefits versus the risks of withholding their antihypertensive medication Hypersensitivity Reactions Including Serum Sickness Hypersensitivity reactions have been reported in patients treated with GAZYVA. Signs of immediate-onset hypersensitivity...
COPIKTRA is an oral treatment option for relapsed CLL/SLL. See Important Safety Info and Medication Guide for information on serious side effects.
These are not all of the possible side effects with RITUXAN HYCELA. Call your doctor for medical advice about side effects. Please see the fullPrescribing Information, includingBOXED WARNINGSandMedication Guide, for additional Important Safety Information. ...
While tolerance is generally good, adverse side effects can include higher infection risk (neutropenia), hypertension, anemia, and pneumonia. BCL2 Targeting Agents Venclexta (venetoclax)is another oral medication approved for all adult cases of CLL. The drug has a positive safety profile and lower...
• Track CLL-specific symptoms and side effects • Gain insights from easy-to-understand charts that record your test results, medication adherence, and more • Access patient education materials • Share your information with your healthcare provider, facilitating more informed discussions during...
Venetoclax is an oral medication developed to target B-cell lymphoma-2 (BCL-2) proteins that promote cancer cell survival in CLL. The API in Venetoclax is the active compound responsible for its pharmacological effects, disrupting BCL-2 proteins and inducing apoptosis in maligna...